Editas Medicine, Inc. Contracts & Agreements

70 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment
Editas Medicine, Inc.
2024
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Editas Medicine, Inc.
2024
Form of Incentive Stock Option Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Editas Medicine, Inc.
2024
Form of Nonstatutory Stock Option Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Editas Medicine, Inc.
2024
Form of Restricted Stock Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Editas Medicine, Inc.
2024
Form of Restricted Stock Unit Award Agreement under the 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Editas Medicine, Inc.
2024
Form of Inducement Stock Option Agreement for the Registrants executive officers
Stock Agreements
Editas Medicine, Inc.
2024
Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers
Stock Agreements
Editas Medicine, Inc.
2024
Summary of Director Compensation Program
Compensation Agreements
Editas Medicine, Inc.
2024
Omnibus Amendment, dated as of February 5, 2024, by and among the Registrant, Broad and Harvard
Editas Medicine, Inc.
2024
Amended and Restated Severance Benefits Plan
Severance Agreements
Editas Medicine, Inc.
2023
Employment Offer Letter, dated May 12, 2023, between the Registrant and Erick Lucera
Employment Agreements
Editas Medicine, Inc.
2023
Separation Agreement, dated May 16, 2023, between the Registrant and Michelle Robertson
Separation Agreements
Editas Medicine, Inc.
2023
Employment Offer Letter, dated July 3, 2023, between the Registrant and Linda C. Burkly
Employment Agreements
Editas Medicine, Inc.
2023
Underwriting Agreement, June 14, 2023, by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group, L.L.C
Underwriting Agreements
Editas Medicine, Inc.
2023
First Amendment to Lease Agreement, dated November 15, 2022 between Registrant and ARE-MA Region No. 55, LLC
Lease Agreements
Editas Medicine, Inc.
Biotechnology
2023
Employment Offer Letter, dated April 13, 2022, between the Registrant and Gilmore ONeill
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2022
Amendment to Employment Offer Letter, dated April 13, 2022, between the Registrant and James C. Mullen
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2022
Employment Offer Letter, dated June 14, 2022, between the Registrant and Baisong Mei
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2022
Amendment to RSU Agreement, dated May 24, 2022, between the Registrant and James C. Mullen
Editas Medicine, Inc.
2022
Amended Severance Benefits Plan
Severance Agreements
Editas Medicine, Inc.
2022
Employment Offer Letter, dated September 22, 2021, between the Registrant and Bruce Eaton
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2021
License Agreement, dated August 29, 2014, between the Registrant and The General Hospital Corporation, d/b/a Massachusetts General Hospital
License Agreements
Editas Medicine, Inc.
Biotechnology
MA
2021
Second Amendment to the Exclusive Patent License Agreement, by and between the Company and The General Hospital Corporation, d/b/a Massachusetts General Hospital, dated November...
License Agreements
Editas Medicine, Inc.
2021
License Agreement, dated October 10, 2014, between the Registrant and Duke University
License Agreements
Editas Medicine, Inc.
Biotechnology
DE
2021
Letter Agreement, dated October 9, 2015, between the Registrant and Duke University
Editas Medicine, Inc.
Biotechnology
2021
License Agreement, dated October 29, 2014, among the Registrant, the President and Fellows of Harvard College, and the Broad Institute, Inc
License Agreements
Editas Medicine, Inc.
2021
License and Collaboration Agreement, dated May 26, 2015, between the Registrant and Juno Therapeutics, Inc
Collaboration Agreements
Editas Medicine, Inc.
2021
Employment Offer Letter, dated April 19, 2021, between the Registrant and Mark S. Shearman
Employment Agreements
Editas Medicine, Inc.
2021
Summary of Non-Employee Director Compensation Program
Compensation Agreements
Editas Medicine, Inc.
Biotechnology
2021
Common Stock Sales Agreement, dated as of May 14, 2021, by and between the Company and Cowen and Company, LLC
Stock Agreements
Editas Medicine, Inc.
2021
Letter Agreement, dated February 15, 2021, by and between the Registrant and Cynthia Collins
Editas Medicine, Inc.
2021
Employment Offer Letter, dated February 14, 2021, between the Registrant and James C. Mullen
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2021
Employment Offer Letter, dated September 25, 2020, between the Registrant and Lisa A. Michaels, M.D
Employment Agreements
Editas Medicine, Inc.
Biotechnology
MA
2021
First Amendment to Sponsored Research Agreement, dated January 11, 2021, between the Registrant and Broad
Editas Medicine, Inc.
2021
Summary of Director Compensation Program
Compensation Agreements
Editas Medicine, Inc.
Biotechnology
2021
Omnibus Amendment, dated as of January 11, 2021, by and between the Registrant and Broad
Editas Medicine, Inc.
Biotechnology
MA
2021
Underwriting Agreement, dated January 20, 2021, by and among the Company, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC
Underwriting Agreements
Editas Medicine, Inc.
2021
Termination Agreement, dated August 5, 2020, by and between the Company and Allergan Sales, LLC
Termination Agreements
Editas Medicine, Inc.
Biotechnology
NY
2020
Separation Agreement, dated as of April 30, 2020, by and between the Company and Judith Abrams
Separation Agreements
Editas Medicine, Inc.
Biotechnology
MA
2020
Advisory Services Agreement, Dated May 1, 2020, by and between the Company and Judith Abrams
Services Agreements
Editas Medicine, Inc.
2020
Underwriting Agreement, dated June 23, 2020, by and between the Company and the Underwriter
Underwriting Agreements
Editas Medicine, Inc.
2020
Common Stock Sales Agreement, dated as of May 15, 2020, by and between the Company and Cowen
Stock Agreements
Editas Medicine, Inc.
Biotechnology
NY
2020
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Editas Medicine, Inc.
Biotechnology
2020
Employment Offer Letter, dated October 11, 2019, between the Registrant and Judith R. Abrams, M.D
Employment Agreements
Editas Medicine, Inc.
Biotechnology
2020
Employment Offer Letter, dated December 27, 2019, between the Registrant and Michelle Robertson
Employment Agreements
Editas Medicine, Inc.
2020
Form of Inducement Stock Option Agreement for the Registrants executive officers
Stock Agreements
Editas Medicine, Inc.
2020
Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers
Stock Agreements
Editas Medicine, Inc.
2020
Amended Severance Benefits Plan
Severance Agreements
Editas Medicine, Inc.
Biotechnology
MA
2020
Letter Agreement, dated as of November 18, 2019, by and among, the Registrant, Broad and Harvard
Editas Medicine, Inc.
Biotechnology
2020
Letter Agreement, dated as of December 16, 2019, by and among, the Registrant, Broad and Harvard
Editas Medicine, Inc.
2020
Second Amended and Restated License and Collaboration Agreement, dated November 11, 2019, between the Registrant and Juno Therapeutics, Inc. (Juno)
Collaboration Agreements
Editas Medicine, Inc.
2020
License and Agreement, dated November 11, 2019, between the Registrant and Juno
License Agreements
Editas Medicine, Inc.
2020
Offer Letter, dated August 6, 2019, by and between the Registrant and Cynthia Collins
Editas Medicine, Inc.
2019
Letter Agreement, dated September 26, 2019, by and between the Registrant and Vic Myer, Ph.D
Editas Medicine, Inc.
Biotechnology
MA
2019
Consulting Agreement, dated January 20, 2019, by and between the Registrant and Cynthia Collins
Consulting Agreements
Editas Medicine, Inc.
2019
Letter Agreement, dated January 19, 2019, by and between the Registrant and Katrine Bosley
Editas Medicine, Inc.
2019
Co-Development and Commercialization Agreement, dated February 22, 2019, by and between the Registrant and Allergan Sales, LLC
Sales Agreements
Editas Medicine, Inc.
Biotechnology
NY
2019
Separation Agreement, by and between the Registrant and Gerald Cox, M.D., Ph.D
Separation Agreements
Editas Medicine, Inc.
2019
Form of Restricted Stock Unit Award Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Editas Medicine, Inc.
Biotechnology
DE
2019
License and Collaboration Agreement, dated May 26, 2015, between the Registrant and Juno Therapeutics, Inc
Collaboration Agreements
Editas Medicine, Inc.
2018
Amended and Restated License and Collaboration Agreement, dated May 3, 2018, between the Registrant and Juno Therapeutics, Inc
Collaboration Agreements
Editas Medicine, Inc.
Biotechnology
NY
2018
Sponsored Research Agreement, dated June 7, 2018, between the Registrant and The Broad Institute, Inc
Editas Medicine, Inc.
2018
Underwriting Agreement, dated December 5, 2017, by and among Editas Medicine, Inc. and Morgan Stanley & Co. LLC
Underwriting Agreements
Editas Medicine, Inc.
2017
Form of Restricted Stock Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Editas Medicine, Inc.
Biotechnology
DE
2017
First Amendment to License Agreement, dated September 1, 2017, between the Registrant and Duke University
License Agreements
Editas Medicine, Inc.
2017
4,000,000 Shares EDITAS MEDICINE, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Editas Medicine, Inc.
2017
FIRST AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT MGH Agreement No: A221317
License Agreements
Editas Medicine, Inc.
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. THE GENERAL HOSPITAL CORPORATION EXCLUSIVE...
License Agreements
Editas Medicine, Inc.
2016
[ ] Shares EDITAS MEDICINE, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Editas Medicine, Inc.
Biotechnology
NY
2016